{"url":"https://lda.senate.gov/api/v1/filings/596ed78e-9163-4e77-8697-e1d412c8ee7a/","filing_uuid":"596ed78e-9163-4e77-8697-e1d412c8ee7a","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2024,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/596ed78e-9163-4e77-8697-e1d412c8ee7a/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Chris Bowlin, Head of Public Policy and Government Affairs","dt_posted":"2025-01-21T15:42:04-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 Connell Drive","registrant_address_2":"Suite 4200","registrant_different_address":false,"registrant_city":"Berkeley Heights","registrant_state":"NJ","registrant_zip":"07922","registrant":{"id":401107712,"url":"https://lda.senate.gov/api/v1/registrants/401107712/","house_registrant_id":56133,"name":"CORMEDIX INC.","description":null,"address_1":"300 Connell Drive","address_2":"Suite 4200","address_3":null,"address_4":null,"city":"Berkeley Heights","state":"NJ","state_display":"New Jersey","zip":"07922","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS BOWLIN","contact_telephone":"+1 202-669-5396","dt_updated":"2026-02-05T15:38:41.364081-05:00"},"client":{"id":56832,"url":"https://lda.senate.gov/api/v1/clients/56832/","client_id":56832,"name":"CORMEDIX INC.","general_description":"Biopharmaceutical company.","client_government_entity":null,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023 H.R. 5074, Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 S. 4469, A bill to improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes S. 4510 - The Kidney Patient Act Issues related to patient access to infection prevention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151435,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"BOWLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}